Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on... see more

CSE:QNTM - Post Discussion

Quantum BioPharma Ltd > Multiple Sclerosis Drugs Market Size is projected $34 b
View:
Post by DavidRosenberg on Mar 15, 2023 6:42am

Multiple Sclerosis Drugs Market Size is projected $34 b

FSD Pharma had lucid MS drug candidate which got health Canada approval to start phase 1 trials for all MS types 

Multiple Sclerosis Drugs Market Size is projected to reach USD 34.03 Billion by 2031, growing at a CAGR of 3.7%: Straits Research

 


https://www.globenewswire.com/news-release/2023/03/08/2623041/0/en/Multiple-Sclerosis-Drugs-Market-Size-is-projected-to-reach-USD-34-03-Billion-by-2031-growing-at-a-CAGR-of-3-7-Straits-Research.html

Comment by Mil_Man54 on Mar 15, 2023 10:44am
And FSD is no where close to seeing any of that money.....thta's what happens when the company is mismanaged and it sole purpose is to enrich the BoD and management as peoven by their actions....not to mention that they do not have enough money to complete any of the trials.....got that Rosenberg..."COMPLETE"....not start.
Comment by DavidRosenberg on Mar 15, 2023 1:25pm
Enriched ? If they have options and shares and stock doesn't go up they can't sell it for proper gains  zeeshan has been buying shares all throughout 2022 he had thhe choice not too thsts why I said your biased your comments and statements  which company works for free without standard corporate salary ??? Don't be dreaming 
Comment by Mil_Man54 on Mar 15, 2023 4:01pm
"Standard corporate salaries" give us a break....is Zeeshan worth $500K annually....are the BoD worth being issues millions of dollars worth of shares for free...not options....given shares.....Zeeshan picks up a few shares for the optics....not because he has confidence in the company....and he makes enough money that he can drop a few grand here and there....I am baffled that you would ...more  
Comment by DavidRosenberg on Mar 15, 2023 1:27pm
Do you expect Kotra and management to work for free ?  ts good that they got some shares as options that means they gotta work their butts off to make shareholder value upside grown.  If not their shares like ours would be worthless  stop being biased and trying to cash doubt with misinformation please state factual info thanks 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities